eXoZymes Inc. (NASDAQ:EXOZ - Get Free Report) shares shot up 8.8% on Monday . The company traded as high as $13.49 and last traded at $13.49. 1,217 shares traded hands during mid-day trading, a decline of 49% from the average session volume of 2,393 shares. The stock had previously closed at $12.40.
eXoZymes Stock Performance
The company has a quick ratio of 6.19, a current ratio of 6.19 and a debt-to-equity ratio of 0.01. The stock's 50 day simple moving average is $10.47 and its two-hundred day simple moving average is $11.66.
eXoZymes (NASDAQ:EXOZ - Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported ($0.28) earnings per share for the quarter.
About eXoZymes
(
Get Free Report)
eXoZymes, Inc is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
Featured Stories
Before you consider eXoZymes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eXoZymes wasn't on the list.
While eXoZymes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
